CAS 273211-28-2

Eletriptan Hydrobromide (3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole monohydrobromide monohydrate)

CAS : 273211-28-2

Analgesics, antipyretics and non-hormonal anti-inflammatory agents

Formule : C₂₂H₂₆N₂O₂S·HBr·H₂O

Couleur et forme : Off-White Light Brown Powder

Masse moléculaire : 382.1715

Ref: 45-1234453

Eletriptan hydrobromide

CAS : 273211-28-2

Eletriptan hydrobromide is a medicinal compound that has been found to have anticancer properties. It works by inhibiting the activity of certain proteins, such as kinases, which are involved in the growth and survival of cancer cells. Studies have shown that Eletriptan hydrobromide can induce apoptosis (cell death) in human and Chinese hamster ovary tumor cells, and can also inhibit cell cycle progression. This compound is an analog of other protein kinase inhibitors that have been used in cancer treatment. Eletriptan hydrobromide has potential therapeutic applications for various types of cancer and is currently being studied for its efficacy in treating different malignancies.

Formule : C₂₂H₂₉BrN₂O₃S

Degré de pureté : Min. 95%

Masse moléculaire : 481.4 g/mol

Ref: 3D-YKA21128